Tower Research Capital (TRC)’s Redhill Biopharma RDHL Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q2 | – | Hold |
0
| – | – | – | 6285 |
|
2023
Q1 | – | Hold |
0
| – | – | – | 6197 |
|
2022
Q4 | – | Sell |
-12
| Closed | -$6K | – | 6282 |
|
2022
Q3 | $6K | Buy |
12
+8
| +200% | +$4K | ﹤0.01% | 5039 |
|
2022
Q2 | $4K | Sell |
4
-3
| -43% | -$3K | ﹤0.01% | 5247 |
|
2022
Q1 | $17K | Sell |
7
-2
| -22% | -$4.86K | ﹤0.01% | 3702 |
|
2021
Q4 | $24K | Sell |
9
-18
| -67% | -$48K | ﹤0.01% | 3473 |
|
2021
Q3 | $123K | Buy |
27
+24
| +800% | +$109K | ﹤0.01% | 2217 |
|
2021
Q2 | $23K | Buy |
3
+1
| +50% | +$7.67K | ﹤0.01% | 3766 |
|
2021
Q1 | $13K | Buy |
+2
| New | +$13K | ﹤0.01% | 4216 |
|
2020
Q4 | – | Hold |
0
| – | – | – | 4820 |
|
2020
Q1 | – | Hold |
0
| – | – | – | 3747 |
|
2019
Q4 | – | Sell |
-1
| Closed | -$8K | – | 4225 |
|
2019
Q3 | $8K | Hold |
1
| – | – | ﹤0.01% | 3088 |
|
2019
Q2 | $5K | Hold |
1
| – | – | ﹤0.01% | 2955 |
|
2019
Q1 | $12K | Buy |
+1
| New | +$12K | ﹤0.01% | 2587 |
|
2017
Q4 | – | Hold |
0
| – | – | – | 3985 |
|
2017
Q3 | – | Hold |
0
| – | – | – | 4154 |
|
2016
Q4 | – | Hold |
0
| – | -$1K | – | 4297 |
|
2016
Q3 | – | Sell |
-1
| Closed | -$7K | – | 3349 |
|
2016
Q2 | $7K | Buy |
+1
| New | +$7K | ﹤0.01% | 3160 |
|
2016
Q1 | – | Hold |
0
| – | – | – | 2920 |
|
2015
Q4 | – | Sell |
-1
| Closed | -$16K | – | 4960 |
|
2015
Q3 | $16K | Buy |
+1
| New | +$16K | ﹤0.01% | 1936 |
|
2015
Q2 | – | Sell |
-3
| Closed | -$38K | – | 4933 |
|
2015
Q1 | $38K | Buy |
3
+2
| +200% | +$25.3K | ﹤0.01% | 1703 |
|
2014
Q4 | $15K | Buy |
+1
| New | +$15K | ﹤0.01% | 1802 |
|
2014
Q3 | – | Sell |
-1
| Closed | -$16K | – | 3312 |
|
2014
Q2 | $16K | Hold |
1
| – | – | ﹤0.01% | 1988 |
|
2014
Q1 | $11K | Buy |
+1
| New | +$11K | ﹤0.01% | 2517 |
|
2013
Q3 | – | Hold |
0
| – | -$3K | – | 4787 |
|
2013
Q2 | – | Hold |
0
| – | – | – | 3320 |
|